(Q39199981)

9 September 2017

Use of Oseltamivir to control influenza complications after bone marrow transplantation (English)

1 reference

9 September 2017

1 reference

1 reference

Machado CM

1

1 reference

9 September 2017

Boas LS

2

1 reference

9 September 2017

Mendes AV

3

1 reference

9 September 2017

da Rocha IF

4

1 reference

9 September 2017

Sturaro D

5

1 reference

9 September 2017

Dulley FL

6

1 reference

9 September 2017

Pannuti CS

7

1 reference

9 September 2017

language of work or name

English

0 references

publication date

1 July 2004

1 reference

Bone Marrow Transplantation

9 September 2017

1 reference

9 September 2017

34

1 reference

9 September 2017

2

1 reference

9 September 2017

111-114

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1704534

9 September 2017

0 references

cites work

Respiratory virus infections after marrow transplant: the Fred Hutchinson Cancer Research Center experience

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704534

Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704534

Low mortality rates related to respiratory virus infections after bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704534

Oseltamivir: a review of its use in influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704534

Epidemiology and seasonality of respiratory tract virus infections in the tropics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704534

Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704534

Granulocyte-macrophage colony-stimulating factor as immunomodulating factor together with influenza vaccination in stem cell transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704534

Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704534

Antibody responses to vaccinations given within the first two years after transplant are similar between autologous peripheral blood stem cell and bone marrow transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704534

inferred from DOI database lookup

7 January 2021

based on heuristic

Rapid diagnosis of respiratory syncytial virus infections in immunocompromised adults.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704534

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.BMT.1704534

1 reference

9 September 2017

1 reference